RecruitingACTRN12607000623493

COHEREX-EU:A Multi-Center Study to Evaluate the Safety and Efficacy of the Coherex FlatStent Patent Foramen Ovale(PFO) Closure System

A Feasibility study of 50 patients with symptomatic Patent ForamenOvale (PFO) undergoing closure of the defect using the Coherex FlatStent Patent Foramen Ovale (PFO) Closure System to evaluate the Safety and Efficacy of the device.


Sponsor

Coherex Medical Inc.

Enrollment

50 participants

Start Date

Oct 1, 2007

Study Type

Interventional

Conditions

Summary

The COHEREX-EU Study is a multi-center registry of the first 50 patients to have their Patent Foramen Ovale closed with the Coheres FlatStent Patent Foramen Ovale (PFO) Closure System. This study will demonstrate the safety and efficacy of the Coheres FlatStent Patent Foramen Ovale (PFO) Closure System.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study is testing a new device called the Coherex FlatStent, which is used to close a small hole in the heart called a Patent Foramen Ovale (PFO). A PFO is a flap-like opening between the two upper chambers of the heart that normally closes shortly after birth, but in some people it stays open. It can sometimes allow blood clots to pass through, increasing the risk of stroke. The device is inserted through a vein without open-heart surgery. The study involves the first 50 patients to receive this device and will track safety and effectiveness. You may be eligible if: - You are between 18 and 65 years of age - You have been diagnosed with a Patent Foramen Ovale (PFO) - Your doctor has recommended closure of the PFO using a non-surgical (percutaneous) approach You may NOT be eligible if: - You have allergies to aspirin, clopidogrel, nickel, or other stent materials - You had a major stroke in the last 2 months or a minor stroke in the last 2 weeks - You have a blood clot inside the heart - You may be pregnant - You have an active infection or sepsis - You have other significant structural heart disease or coronary artery disease - You have a known sustained irregular heart rhythm (arrhythmia) Talk to your doctor about whether this trial might be right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The Coherex FlatStent Patent Foramen Ovale (PFO) Closure System is a implant placed percutaneously by an interventional cardioligist into a patent foramen ovale to close the congenital defect. Patien

The Coherex FlatStent Patent Foramen Ovale (PFO) Closure System is a implant placed percutaneously by an interventional cardioligist into a patent foramen ovale to close the congenital defect. Patients will be observed for 6 months post intervention.


Locations(2)

Germany

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000623493